Zhiwen Lian
Foshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Association between lipid-lowering drug targets and the risk of cystic kidney disease: a drug-target Mendelian randomization analysis.
Journal: Renal failure
Published: April 27, 2025
COMMD5 is involved in the mechanisms of hypotension after parathyroidectomy in patients receiving hemodialysis.
Journal: European journal of pharmacology
Published: October 07, 2022
GAP-43 ameliorates Podocyte injury by decreasing nuclear NFATc1 expression.
Journal: Biochemistry and biophysics reports
Published: May 27, 2021
Thromboxane A2 is involved in the development of hypertension in chronic kidney disease rats.
Journal: European journal of pharmacology
Published: March 03, 2021
Clinical features of severe patients infected with 2019 novel coronavirus: a systematic review and meta-analysis.
Journal: Annals of translational medicine
Published: June 23, 2020
The Krüppel-like factor 15-NFATc1 axis ameliorates podocyte injury: a novel rationale for using glucocorticoids in proteinuria diseases.
Journal: Clinical science (London, England : 1979)
Published: January 22, 2020
Receptor activator of NF-κB mediates podocyte injury in diabetic nephropathy.
Journal: Kidney international
Published: December 17, 2019
Treatment of Uremic Tumoral Calcinosis in Maintenance Hemodialysis Patients.
Journal: Blood purification
Published: October 31, 2019
Soluble Urokinase Plasminogen Activator Receptor is Associated with Coronary Artery Calcification and Cardiovascular Disease in Patients Undergoing Hemodialysis.
Journal: Kidney & blood pressure research
Published: February 16, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026